Veeva Vault CRM Chosen by Biogen to Enhance Treatment Delivery Worldwide

Veeva Vault CRM Selected by Biogen



In a significant announcement today, Veeva Systems (NYSE: VEEV) revealed that biotech leader Biogen has opted for Veeva Vault CRM on a global scale. This collaboration marks a pivotal step in Biogen's mission to bring innovative treatments to the market efficiently and effectively.

Tom Schwenger, the president and CCO of Veeva, expressed pride in this partnership, stating, "We are honored to provide Vault CRM as the commercial backbone for Biogen in their mission to deliver medications that significantly impact patients' lives." Schwenger emphasized the necessity of a flexible commercial strategy to navigate the complexities of launching treatment options in today’s healthcare landscape.

Biogen's decision to adopt the Vault CRM suite reflects a mutual commitment to enhancing customer experience and fostering innovation within the pharmaceutical industry. Guy Hadari, Biogen's Senior Vice President and Global CIO, shared his enthusiasm about expanding their partnership with Veeva. He noted, "Moving to Vault CRM will elevate our strategic alignment with Veeva, ultimately benefiting our operations and client relationships."

The Vault CRM suite is designed to support agents in producing commercial evidence while employing cutting-edge technologies. One of its notable components, the Agentic Call Report, serves as a crucial tool for gathering data necessary to understand market dynamics and patient needs better.

For Veeva Systems, this collaboration represents more than just a business transaction; it aligns with their broader vision of revolutionizing the life sciences sector through customizable cloud solutions. Veeva caters to over 1,500 clients, ranging from global pharmaceutical giants to burgeoning biotech firms. This partnership with Biogen is a testament to Veeva's commitment to providing excellence in service and product innovation, ensuring that stakeholders from various sectors are prioritized and supported.

As a Public Benefit Corporation, Veeva is steadfast in aligning its goals with the interests of all stakeholders, thereby signifying an industry-wide commitment to balancing profitability with social responsibility. This aspect is increasingly vital in today’s market landscape where ethical considerations are paramount.

In summary, the collaboration between Biogen and Veeva represents a significant advancement in the move toward Agile and patient-centric healthcare solutions. Together, both companies aspire to enhance treatment accessibility and efficacy, ensuring that groundbreaking medical technologies reach populations that need them most.

Looking Ahead


The integration of Veeva Vault CRM into Biogen's operations stands to redefine the way pharmaceutical companies approach market strategies and patient engagements. As this partnership evolves, it will be worth monitoring how both companies adapt to emerging challenges and seize new opportunities within the life sciences arena.

About Veeva Systems


Veeva Systems is at the forefront of delivering cloud solutions specifically designed for the life sciences industry. With a strong focus on innovation and customer success, Veeva provides vital applications, data, and consulting services that empower organizations like Biogen to thrive in a rapidly changing landscape.

For further information on Veeva and its offerings, visit veeva.com.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.